SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: richard davis who wrote (965)12/5/1996 6:18:00 PM
From: John H. Farro   of 4342
 
Rick, when I spoke to the guy at Paracelsian's investor relations firm he said the subjects of the experiment enrolled on a staggered basis since PRLN could not get enough subjects all at once. I am guessing that Babish has results from those who enrolled early on and that they based their decision to market AndroVir on the data from the these subjects. If this is the case, then at least some of the subjects probably showed some improvement and Babish is just waiting for the data on those who enrolled later. This is only a guess. Maybe Paul can verify it or shoot down my guess. I will call the company in a couple of weeks if we don't hear anything by then.

Robin
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News